AI
Friday, January 19, 2007 6:58:47 PM
>>> However, DOR said it cannot consider the offer at this time as the company had signed a letter of intent which grants Sigma-Tau Pharmaceuticals Inc., a unit of Italy-based Sigma-Tau Group, exclusive right to negotiate for its lead product. <<<
It sounds like this means rhey can only sell the rights to Sigma-Tau. Is this correct , or does it mean right of first refusal ?
Whatever , it seems this will set a considerably higher floor on DORB pps for a while , at least. Wish I had some myself.
It sounds like this means rhey can only sell the rights to Sigma-Tau. Is this correct , or does it mean right of first refusal ?
Whatever , it seems this will set a considerably higher floor on DORB pps for a while , at least. Wish I had some myself.
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
